85
32
Growth Score 85 in past quarter
-3 pts
Heat Score 32 in past quarter
19 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
307716
Miramoon Pharma is a biotechnology company based in San Sebastián, that develops first-in-class small-molecule medicines.
- Amalia Capilla: Chief Executive Officer
- Iciar Gomeza: CFO
About the Company
Miramoon Pharma is a biotechnology company based in San Sebastián, Spain, that develops first-in-class small-molecule medicines targeting musculoskeletal, cardiovascular, and neurodegenerative diseases, including rare genetic conditions. The company’s lead programs focus on stabilizing calcium channels and reducing oxidative stress, with its main
candidate, MP-004, advancing preclinical studies for inherited retinal disorders like retinitis pigmentosa. Miramoon’s pipeline also includes candidates for conditions such as Duchenne muscular dystrophy, myotonic dystrophy type 1, ALS, and Alzheimer’s disease.